- Home
- MRNS vs RVSB Comparison
MRNS vs RVSB Comparison
Compare MRNS & RVSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNS
- RVSB
- Stock Information
- Founded
- MRNS 2003
- RVSB 1923
- Country
- MRNS United States
- RVSB United States
- Employees
- MRNS N/A
- RVSB N/A
- Industry
- MRNS Biotechnology: Pharmaceutical Preparations
- RVSB Savings Institutions
- Sector
- MRNS Health Care
- RVSB Finance
- Exchange
- MRNS Nasdaq
- RVSB Nasdaq
- Market Cap
- MRNS 76.0M
- RVSB 86.3M
- IPO Year
- MRNS 2014
- RVSB 1993
- Fundamental
- Price
- MRNS $1.40
- RVSB $4.44
- Analyst Decision
- MRNS Buy
- RVSB
- Analyst Count
- MRNS 6
- RVSB 0
- Target Price
- MRNS $10.50
- RVSB N/A
- AVG Volume (30 Days)
- MRNS 322.2K
- RVSB 19.9K
- Earning Date
- MRNS 11-05-2024
- RVSB 10-24-2024
- Dividend Yield
- MRNS N/A
- RVSB 4.50%
- EPS Growth
- MRNS N/A
- RVSB N/A
- EPS
- MRNS N/A
- RVSB 0.09
- Revenue
- MRNS $30,263,000.00
- RVSB $46,872,000.00
- Revenue This Year
- MRNS $20.42
- RVSB N/A
- Revenue Next Year
- MRNS $57.03
- RVSB $12.93
- P/E Ratio
- MRNS N/A
- RVSB $48.82
- Revenue Growth
- MRNS 16.56
- RVSB N/A
- 52 Week Low
- MRNS $1.05
- RVSB $3.30
- 52 Week High
- MRNS $11.26
- RVSB $6.57
- Technical
- Relative Strength Index (RSI)
- MRNS 53.94
- RVSB 44.09
- Support Level
- MRNS $1.35
- RVSB $4.45
- Resistance Level
- MRNS $1.53
- RVSB $4.71
- Average True Range (ATR)
- MRNS 0.09
- RVSB 0.14
- MACD
- MRNS 0.01
- RVSB -0.03
- Stochastic Oscillator
- MRNS 53.57
- RVSB 29.64
About MRNS Marinus Pharmaceuticals Inc.
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.